Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|March 25, 1990
Thiol-based inhibitors of mammalian collagenase. Substituted amide and peptide derivatives of the leucine analogue, 2-[(R,S)-mercaptomethyl]-4-methylpentanoic acidK Darlak, R B Miller, M S Stack, et al.
Oncogene|June 20, 2017
Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasisY Klymenko, O Kim, E Loughran, et al.
International Journal of Cancer|September 4, 1996
Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrinT L Moser, S V Pizzo, L M Bafetti, et al.
Cancer|October 24, 1997
Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cellsD A Fishman, L M Bafetti, S Banionis, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 2, 2010
Masticatory biomechanics and masseter fiber-type plasticityM J Ravosa, J Ning, D B Costley, et al.
Gynecologic Oncology|July 1, 1996
Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: purification of matrix metalloproteinase 2T N Young, G C Rodriguez, A R Rinehart, et al.
American Journal of Obstetrics and Gynecology|May 1, 1994
Coordinate expression of urinary-type plasminogen activator and its receptor accompanies malignant transformation of the ovarian surface epitheliumT N Young, G C Rodriguez, T L Moser, et al.
International Journal of Cancer|February 15, 1994
Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinomaT L Moser, T N Young, G C Rodriguez, et al.
Gynecologic Oncology|February 13, 2001
Regulation of invasion of epithelial ovarian cancer by transforming growth factor-betaG C Rodriguez, C Haisley, J Hurteau, et al.
International Journal of Cancer|June 4, 1998
HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPIC N Rao, B Cook, Y Liu, et al.
Pageof 6